Literature DB >> 29284681

A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia.

Matthew S Zabriskie1, Orlando Antelope1, Anupam R Verma2, Lauren R Draper2, Christopher A Eide3,4, Anthony D Pomicter1, Thai Hoa Tran5, Brian J Druker3,4, Jeffrey W Tyner3, Rodney R Miles1,6, James M Graham1,7, Jae-Yeon Hwang1,7, Katherine E Varley1,7, Reha M Toydemir6,8, Michael W Deininger1,9, Elizabeth A Raetz10,2, Thomas O'Hare10,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29284681      PMCID： PMC5792293          DOI： 10.3324/haematol.2017.165282

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

Authors:  K R Schultz; A Carroll; N A Heerema; W P Bowman; A Aledo; W B Slayton; H Sather; M Devidas; H W Zheng; S M Davies; P S Gaynon; M Trigg; R Rutledge; D Jorstad; N Winick; M J Borowitz; S P Hunger; W L Carroll; B Camitta
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

2.  Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.

Authors:  Bettina Reismüller; Andishe Attarbaschi; Christina Peters; Michael N Dworzak; Ulrike Pötschger; Christian Urban; Franz-Martin Fink; Bernhard Meister; Klaus Schmitt; Karin Dieckmann; Günter Henze; Oskar A Haas; Helmut Gadner; Georg Mann
Journal:  Br J Haematol       Date:  2008-12-05       Impact factor: 6.998

3.  Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

Authors:  Kimmo Porkka; Perttu Koskenvesa; Tuija Lundán; Johanna Rimpiläinen; Satu Mustjoki; Richard Smykla; Robert Wild; Roger Luo; Montserrat Arnan; Benoit Brethon; Lydia Eccersley; Henrik Hjorth-Hansen; Martin Höglund; Hana Klamova; Håvar Knutsen; Suhag Parikh; Emmanuel Raffoux; Franz Gruber; Finella Brito-Babapulle; Hervé Dombret; Rafael F Duarte; Erkki Elonen; Ron Paquette; C Michel Zwaan; Francis Y F Lee
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

4.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

5.  Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.

Authors:  Anja Möricke; Martin Zimmermann; Maria Grazia Valsecchi; Martin Stanulla; Andrea Biondi; Georg Mann; Franco Locatelli; Giovanni Cazzaniga; Felix Niggli; Maurizio Aricò; Claus R Bartram; Andishe Attarbaschi; Daniela Silvestri; Rita Beier; Giuseppe Basso; Richard Ratei; Andreas E Kulozik; Luca Lo Nigro; Bernhard Kremens; Jeanette Greiner; Rosanna Parasole; Jochen Harbott; Roberta Caruso; Arend von Stackelberg; Elena Barisone; Claudia Rössig; Valentino Conter; Martin Schrappe
Journal:  Blood       Date:  2016-02-17       Impact factor: 22.113

6.  Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

Authors:  Jane F Apperley; Martine Gardembas; Junia V Melo; Robin Russell-Jones; Barbara J Bain; E Joanna Baxter; Andrew Chase; Judith M Chessells; Marie Colombat; Claire E Dearden; Sasa Dimitrijevic; François-X Mahon; David Marin; Zariana Nikolova; Eduardo Olavarria; Sandra Silberman; Beate Schultheis; Nicholas C P Cross; John M Goldman
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

7.  Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening.

Authors:  Jeffrey W Tyner; Wayne F Yang; Armand Bankhead; Guang Fan; Luke B Fletcher; Jade Bryant; Jason M Glover; Bill H Chang; Stephen E Spurgeon; William H Fleming; Tibor Kovacsovics; Jason R Gotlib; Stephen T Oh; Michael W Deininger; Christian Michel Zwaan; Monique L Den Boer; Marry M van den Heuvel-Eibrink; Thomas O'Hare; Brian J Druker; Marc M Loriaux
Journal:  Cancer Res       Date:  2012-10-18       Impact factor: 12.701

8.  EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

Authors:  Claire Schwab; Sarra L Ryan; Lucy Chilton; Alannah Elliott; James Murray; Stacey Richardson; Christopher Wragg; John Moppett; Michelle Cummins; Oliver Tunstall; Catriona A Parker; Vaskar Saha; Nicholas Goulden; Ajay Vora; Anthony V Moorman; Christine J Harrison
Journal:  Blood       Date:  2016-02-12       Impact factor: 22.113

9.  The landscape of kinase fusions in cancer.

Authors:  Nicolas Stransky; Ethan Cerami; Stefanie Schalm; Joseph L Kim; Christoph Lengauer
Journal:  Nat Commun       Date:  2014-09-10       Impact factor: 14.919

10.  NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.

Authors:  K Byrgazov; R Kastner; M Gorna; G Hoermann; M Koenig; C B Lucini; R Ulreich; M Benesch; V Strenger; H Lackner; W Schwinger; P Sovinz; O A Haas; M van den Heuvel-Eibrink; C M Niemeyer; O Hantschel; P Valent; G Superti-Furga; C Urban; M N Dworzak; T Lion
Journal:  Leukemia       Date:  2015-08-30       Impact factor: 11.528
View more
  4 in total

1.  Knockdown of AGGF1 inhibits the invasion and migration of gastric cancer via epithelial-mesenchymal transition through Wnt/β-catenin pathway.

Authors:  Han-Hui Yao; Ya-Jun Zhao; Yi-Fu He; Da-Bing Huang; Wei Wang
Journal:  Cancer Cell Int       Date:  2019-02-27       Impact factor: 5.722

Review 2.  Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.

Authors:  Anna Mroczek; Joanna Zawitkowska; Jerzy Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

3.  Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.

Authors:  Danika Di Giacomo; Martina Quintini; Valentina Pierini; Fabrizia Pellanera; Roberta La Starza; Paolo Gorello; Caterina Matteucci; Barbara Crescenzi; Paolo Fabio Fiumara; Marinella Veltroni; Erika Borlenghi; Francesco Albano; Fabio Forghieri; Monica Maccaferri; Francesca Bettelli; Mario Luppi; Antonio Cuneo; Giuseppe Rossi; Cristina Mecucci
Journal:  Ann Hematol       Date:  2021-12-02       Impact factor: 3.673

4.  FHA domain of AGGF1 is essential for its nucleocytoplasmic transport and angiogenesis.

Authors:  Cui-Fang Zhang; Han-Ming Wang; Andong Wu; Yang Li; Xiao-Li Tian
Journal:  Sci China Life Sci       Date:  2021-01-18       Impact factor: 6.038
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.